US Patent Litigations are now available. Check here

Explore Bristol Myers Squibb Ireland Unlimited's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3246021Nov 13, 2019Apixaban Formulations12
EP3251660Oct 16, 2019Apixaban Formulations10
EP3257500Oct 16, 2019Apixaban Formulations10
EP3017811Dec 5, 2018Apixaban Formulations9
EP3054926Jul 25, 2018Hiv Treatment Formulation Of Atazanavir And Cobicistat1